LTA4H, leukotriene A4 hydrolase, 4048

N. diseases: 63; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.330 Biomarker disease BEFREE The authors sought to develop combined positron emission tomography (PET) dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) to quantify plaque inflammation, permeability, and burden to evaluate the efficacy of a leukotriene A4 hydrolase (LTA4H) inhibitor in a rabbit model of atherosclerosis. 29413439 2018
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.330 Biomarker disease CTD_human The abundant expression of LTA4H and correlation with plaque instability identify LTA4H as a potential target for pharmacological intervention in treatment of human atherosclerosis. 16698924 2006
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.330 Biomarker disease BEFREE Recently, leukotriene-based inflammation has also been shown to play an important role in atherosclerosis: ALOX5AP and LTA4H, both genes in the leukotriene biosynthesis pathway, have individually been shown to be associated with various cardiovascular disease (CVD) phenotypes. 19130089 2009
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.330 Biomarker disease BEFREE The eicosanoid genes ALOX5, ALOX5AP and LTA4H have been implicated in atherosclerosis. 25721704 2015
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.310 GeneticVariation disease BEFREE We examined the association, separately in men and women, between seven single nucleotide polymorphisms (SNPs) in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and 12 SNPs in the leukotriene A4 hydrolase (LTA4H) gene and depression in 1368 white subjects (30.4% female) referred for cardiovascular evaluation. 19622707 2009
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.310 Biomarker disease PSYGENET We examined the association, separately in men and women, between seven single nucleotide polymorphisms (SNPs) in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and 12 SNPs in the leukotriene A4 hydrolase (LTA4H) gene and depression in 1368 white subjects (30.4% female) referred for cardiovascular evaluation. 19622707 2009
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.310 Biomarker disease PSYGENET We examined the association, separately in men and women, between seven single nucleotide polymorphisms (SNPs) in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and 12 SNPs in the leukotriene A4 hydrolase (LTA4H) gene and depression in 1368 white subjects (30.4% female) referred for cardiovascular evaluation. 19622707 2009
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.310 GeneticVariation disease BEFREE We examined the association, separately in men and women, between seven single nucleotide polymorphisms (SNPs) in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and 12 SNPs in the leukotriene A4 hydrolase (LTA4H) gene and depression in 1368 white subjects (30.4% female) referred for cardiovascular evaluation. 19622707 2009
CUI: C0023893
Disease: Liver Cirrhosis, Experimental
Liver Cirrhosis, Experimental
0.300 Biomarker disease CTD_human Systems level analysis and identification of pathways and networks associated with liver fibrosis. 25380136 2014
CUI: C0004096
Disease: Asthma
Asthma
0.280 GeneticVariation disease BEFREE The results indicated that LTA4H A-9188>G, TNFα G-308>A and IL-4Rα A1727>G polymorphisms were significantly associated with the development of difficult asthma in paediatric patients (p<0.001, p = 0.019 and p = 0.037, respectively). 23573270 2013
CUI: C0004096
Disease: Asthma
Asthma
0.280 Biomarker disease RGD The expression of 5-LO and LTA4-H mRNA, and 5-LO protein levels were increased in lung tissue and cerebral cortex in asthma rats. 15715933 2005
CUI: C0004096
Disease: Asthma
Asthma
0.280 AlteredExpression disease BEFREE LPS induced significant expression of ANXA1 and LTA4H in asthmatics when compared to COPD patients and healthy subjects. 25634111 2014
CUI: C0004096
Disease: Asthma
Asthma
0.280 Biomarker disease BEFREE These data suggest that polymorphisms spanning ALOX5AP, LTA4H and the LTB4R locus are not major determinants of baseline lung function in smokers, but provide tentative evidence for LTA4H rs1978331C (intron 11) in determining baseline FEV1 and FEV1/FVC ratio in Caucasian Smokers in addition to our previously identified role in asthma susceptibility. 22206291 2011
CUI: C0004096
Disease: Asthma
Asthma
0.280 Biomarker disease BEFREE ALOX5AP and LTA4H are associated with asthma susceptibility, suggesting a role for LTB4 in disease. 23167751 2012
CUI: C0004096
Disease: Asthma
Asthma
0.280 GeneticVariation disease BEFREE To assess the contribution of LTA4H and ALOX5AP polymorphism to asthma and allergy susceptibility. 18547289 2008
CUI: C0004096
Disease: Asthma
Asthma
0.280 Biomarker disease BEFREE This region harbours a number of candidate genes for asthma and atopy, including stem cell factor (SCF), leukotriene A4 hydrolase (LTA4H), thyroid receptor 2 (TR2), and signal transducer and activator of transcription 6 (STAT6). 11069563 2000
CUI: C0004096
Disease: Asthma
Asthma
0.280 Biomarker disease BEFREE Leukotriene A4 Hydrolase Activation and Leukotriene B4 Production by Eosinophils in Severe Asthma. 30352167 2019
CUI: C0004096
Disease: Asthma
Asthma
0.280 Biomarker disease LHGDN Single point analyses identified association (P < 0.05) between SNPs SG13S114, SG13S89, SG13S41 (ALOX5AP), rs1978331 (LTA4H) and asthma and/or related phenotypes. 18547289 2008
CUI: C0004096
Disease: Asthma
Asthma
0.280 GeneticVariation disease BEFREE Two SNPs within LTA4H (rs17525488 and rs2540493) were protective for asthma in Latinos (P=0.007 and 0.05, respectively). 20067482 2010
CUI: C0007137
Disease: Squamous cell carcinoma
Squamous cell carcinoma
0.200 Biomarker disease RGD Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2. 17985342 2008
CUI: C0751688
Disease: Malignant Squamous Cell Neoplasm
Malignant Squamous Cell Neoplasm
0.200 Biomarker disease RGD Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: inefficacy of genetic or pharmacological disruption of COX-2. 17985342 2008
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 Biomarker disease BEFREE Genetic variation in the genes ALOX5 (arachidonate 5-lipoxygenase), ALOX5AP (arachidonate 5-lipoxygenase-activating protein) and LTA4H (leukotriene A4 hydrolase) has previously been shown to contribute to the risk of MI (myocardial infarction) in Caucasian and African American populations. 30678701 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 GeneticVariation disease BEFREE In FLAP, two SNPs were negatively associated with incident MI (rs9551963 & rs17222842) while one SNP (rs2247570) located in LTA4-H, was associated with higher risk of MI when comparing subjects with two copies of the variant allele to homozygotes for the wild type. 27893808 2016
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 Biomarker disease BEFREE Although there was limited inter-study concordance of important loci, two gene variants in the leukotriene pathway (ALOX5AP and LTA4) have emerged as susceptibility factors for myocardial infarction (MI). 16987874 2006
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 Biomarker disease BEFREE Here we show that a haplotype (HapK) spanning the LTA4H gene encoding leukotriene A4 hydrolase, a protein in the same biochemical pathway as ALOX5AP, confers modest risk of myocardial infarction in an Icelandic cohort. 16282974 2006